A 6-oxo-1,6-dihydro-pyridazine derivative for use in the treatment of hepatocellular carcinoma (HCC)

• 收藏
• 分享

专利权人:

Merck Patent GmbH

发明人:

FRIESE-HAMIM, Manja,BLADT, Friedhelm

申请号：

ES13776720

公开号：

ES2646913T3

申请日:

2013.10.04

申请国别(地区):

ES

年份:

2017

代理人:

摘要：

3- (1- {3- [5- (1-Methyl-piperidin-4-ylmethoxy) -pyrimidin-2-yl] -benzyl} -6-oxo-1,6-dihydro-pyridazin-3-yl) -benzonitrile, or a pharmaceutically acceptable salt and / or solvate thereof, for use in the treatment of hepatocellular carcinoma (HCC).El 3-(1-{3-[5-(1-metil-piperidin-4-ilmetoxi)-pirimidin-2-il]-bencil}-6-oxo-1,6-dihidro-piridazin-3-il)-benzonitrilo, o una sal y/o un solvato farmacéuticamente aceptable de éste, para usar en el tratamiento del carcinoma hepatocelular (HCC).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/